558 related articles for article (PubMed ID: 8401944)
21. Distinct receptors for cholecystokinin and gastrin on canine fundic D-cells.
DelValle J; Chiba T; Park J; Yamada T
Am J Physiol; 1993 May; 264(5 Pt 1):G811-5. PubMed ID: 8098910
[TBL] [Abstract][Full Text] [Related]
22. Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.
Singh L; Lewis AS; Field MJ; Hughes J; Woodruff GN
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1130-3. PubMed ID: 1996314
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the CCKB receptor antagonism of virginiamycin in guinea-pig ileum longitudinal myenteric plexus.
Corsi M; Pojani G; Dal Forno G; Pietra C; Gaviraghi G; Trist D
Br J Pharmacol; 1993 Apr; 108(4):1164-8. PubMed ID: 8485626
[TBL] [Abstract][Full Text] [Related]
24. Cytosolic Ca2+ evaluation in rabbit parietal cells: a novel method to screen gastrin receptor antagonists.
Letari O; Mennuni L; Revel L; Colombo S; Makovec F
Eur J Pharmacol; 1996 Jun; 306(1-3):325-33. PubMed ID: 8813647
[TBL] [Abstract][Full Text] [Related]
25. A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260.
Lotti VJ; Chang RS
Eur J Pharmacol; 1989 Mar; 162(2):273-80. PubMed ID: 2721567
[TBL] [Abstract][Full Text] [Related]
26. Characterization of cholecystokinin receptors on the human gallbladder.
Tokunaga Y; Cox KL; Coleman R; Concepcion W; Nakazato P; Esquivel CO
Surgery; 1993 Feb; 113(2):155-62. PubMed ID: 7679224
[TBL] [Abstract][Full Text] [Related]
27. CCK-B (gastrin) receptor regulates gastric histamine release and acid secretion.
Sandvik AK; Waldum HL
Am J Physiol; 1991 Jun; 260(6 Pt 1):G925-8. PubMed ID: 1711780
[TBL] [Abstract][Full Text] [Related]
28. Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat.
Schmassmann A; Garner A; Flogerzi B; Hasan MY; Sanner M; Varga L; Halter F
Gut; 1994 Feb; 35(2):270-4. PubMed ID: 8307482
[TBL] [Abstract][Full Text] [Related]
29. Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist.
Chang RS; Lotti VJ
Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4923-6. PubMed ID: 3014520
[TBL] [Abstract][Full Text] [Related]
30. Effects of cholecystokinin and cholinergic receptor blockade on guinea pig pepsinogen secretion.
Basson MD; Adrian TE; Modlin IM
Scand J Gastroenterol; 1990 Aug; 25(8):825-33. PubMed ID: 2402588
[TBL] [Abstract][Full Text] [Related]
31. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
[TBL] [Abstract][Full Text] [Related]
32. Both CCK-A and CCK-B/gastrin receptors mediate pepsinogen release in guinea pig gastric glands.
Lin CW; Bianchi BR; Miller TR; Witte DG; Wolfram CA
Am J Physiol; 1992 Jun; 262(6 Pt 1):G1113-20. PubMed ID: 1616041
[TBL] [Abstract][Full Text] [Related]
33. Electrophysiological and autoradiographical evidence for cholecystokinin A receptors on rat isolated nodose ganglia.
Widdop RE; Krstew E; Mercer LD; Carlberg M; Beart PM; Jarrott B
J Auton Nerv Syst; 1994; 46(1-2):65-73. PubMed ID: 8120343
[TBL] [Abstract][Full Text] [Related]
34. Heterogeneity of CCK-B receptors involved in animal models of anxiety.
Derrien M; McCort-Tranchepain I; Ducos B; Roques BP; Durieux C
Pharmacol Biochem Behav; 1994 Sep; 49(1):133-41. PubMed ID: 7816864
[TBL] [Abstract][Full Text] [Related]
35. Characterization of neuronal cholecystokinin receptor by L-364,718 in Auerbach's plexus.
Zelles T; Harsing LG; Vizi ES
Eur J Pharmacol; 1990 Mar; 178(1):101-4. PubMed ID: 2332026
[TBL] [Abstract][Full Text] [Related]
36. Direct contractile effect of cholecystokinin octapeptide on caecal circular smooth muscle cells of guinea pig via both CCK-A and CCK-B/gastrin receptors.
Motomura Y; Chijiiwa Y; Iwakiri Y; Nawata H
Life Sci; 1997; 60(7):499-504. PubMed ID: 9042379
[TBL] [Abstract][Full Text] [Related]
37. The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
Singh L; Field MJ; Hughes J; Menzies R; Oles RJ; Vass CA; Woodruff GN
Br J Pharmacol; 1991 Sep; 104(1):239-45. PubMed ID: 1686205
[TBL] [Abstract][Full Text] [Related]
38. "Gastrin" and "CCK" receptors on histamine- and somatostatin-containing cells from rabbit fundic mucosa-II. Characterization by means of selective antagonists (L-364,718 and L-365,260).
Roche S; Gusdinar T; Bali JP; Magous R
Biochem Pharmacol; 1991 Jul; 42(4):771-6. PubMed ID: 1714276
[TBL] [Abstract][Full Text] [Related]
39. Subtype-selective cholecystokinin receptor antagonists block cholecystokinin modulation of dopamine-mediated behaviors in the rat mesolimbic pathway.
Crawley JN
J Neurosci; 1992 Sep; 12(9):3380-91. PubMed ID: 1527584
[TBL] [Abstract][Full Text] [Related]
40. CCKA and CCKB receptor subtypes both mediate the effects of CCK-8 on myenteric neurons in the guinea-pig ileum.
Schutte IW; Akkermans LM; Kroese AB
J Auton Nerv Syst; 1997 Dec; 67(1-2):51-9. PubMed ID: 9470144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
